| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V61703 | Valziflocept (BAX1810; TAK-752) | 1804910-11-9 | Valziflocept (BAX1810; TAK-752) is a recombinant soluble human FcγRIIb receptor that targets Fc and FcγR. |
|
V61744 | Vanutide cridificar (ACC-001; PF 05236806) | 886584-10-7 | Vanutide cridificar (ACC-001) is an amino-terminal Aβ1-7 peptide conjugate. |
|
V58014 | Varisacumab (R 84 (antibody); GNR-011) | 1610010-60-0 | Varisacumab (R 84) is an antibody. |
|
V57841 | Vatelizumab (GBR500) | 1238217-55-4 | Vatelizumab (GBR500) is a monoclonal antibody (mAb) that targets the α2 subunit (CD49b) of very late antigen 2 (VLA-2). |
|
V59377 | Verzistobart | 2649466-18-0 | Verzistobart is an IgG1κ antibody targeting the hepatitis A virus cellular receptor HAVCR2. |
|
V64323 | Vibostolimab | 2231305-30-7 | Vibostolimab is an anti-TIGIT (T cell immunoglobulin and ITIM domain) monoclonal antibody (mAb). |
|
V81741 | Vixtimotamab (AMV-564; TandAb T564) | Vixtimotamab (AMV-564; TandAb T564) is a bispecific tetravalent tandem antibody (TandAb) targeting human CD33 and CD3 antigens. | |
|
V64416 | Vonlerolizumab (Pogalizumab; MOXR 0916) | 1638935-72-4 | Vonlerolizumab (MOXR 0916) is a humanized IgG agonist OX40-specific monoclonal antibody (mAb). |
|
V64418 | Vopratelimab (JTX 2011) | 2039148-04-2 | Vopratelimab (JTX-2011) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody (mAb) that specifically binds to inducible T cell CO stimulator (ICOS). |
|
V64532 | Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) | 1165740-62-4 | Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) is an anti-human CD70 antibody. |
|
V62498 | XmAb 5592 | 1221901-33-2 | XmAb 5592 is a humanized Fc-engineered anti-HM1.24 antibody that enhances binding to FcγRIIIa and FcγRIIIa receptors, enhancing HM1 via antibody-dependent cellular cytotoxic effect (ADCC) and antibody-dependent cellular phagocytosis (ADCP). |
|
V58443 | Zanolimumab (Anti-Human CD4 Recombinant Antibody) | 652153-01-0 | Zanolimumab (Anti-Human CD4 Recombinant Antibody) is a human monoclonal antibody (mAb) that targets CD4. |
|
V59173 | Ziralimumab (ABX-RB2) | 1427008-29-4 | Ziralimumab (ABX-RB2) is an anti-human CD147/BSG monoclonal antibody (mAb) for immunosuppression. |
|
V59776 | Zovostotug | 2756228-84-7 | Zovostotug is a monoclonal antibody (mAb) against human CD163 (type 1 cysteine-rich domain scavenger receptor M130). |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
